Yield of same day dual endoscopy for patients referred for assessment of positive Fecal Occult Blood Test.

Not Applicable

Recruiting

• Conditions: Bowel Cancer screening; Upper gastrointestinal tract pathology; Gastric and esophageal cancers; Peptic ulcer disease; Celiac disease; Iron deficiency anemia; Cancer - Bowel - Back passage (rectum) or large bowel (colon); Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon; Cancer - Bowel - Small bowel (duodenum and ileum); Blood - Anaemia

• Registration Number: ACTRN12621000984897
• Lead Sponsor: Princess Alexandra Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-07-27
• Last Update Posted: 9 January 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

All patients referred for investigation of positive FOBT will be considered for participation in study.

Exclusion Criteria

None

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.To assess the frequency of common gastrointestinal conditions (namely IDA and Celiac disease) and gastrointestinal symptoms in patients referred for evaluation of positive FOBT. This is a composite primary outcome and this will be assessed from endoscopy.[ To be assessed on the day of the procedure]

Secondary Outcome Measures

Name	Time	Method
2.To determine the frequency of both upper and lower intestinal lesions in asymptomatic FOBT-positive patients and those with gastrointestinal symptoms.This is a composite secondary outcome and will be assessed from the endoscopy.[ To be assessed on the day of the procedure]